Cardiovascular Ultrasound Market Report 2026

Cardiovascular Ultrasound Market Overview

• Cardiovascular Ultrasound market size has reached to $2.58 billion in 2025 • Expected to grow to $3.79 billion in 2030 at a compound annual growth rate (CAGR) of 8.3% • Growth Driver: Cardiovascular Ultrasound Market Set To Surge Amid Rising Prevalence Of Cardiovascular Disease • Market Trend: Portable Handheld Ultrasound Imaging System For Enhanced Cardiac And Vascular Assessments • North America was the largest region in 2025 and Europe is the fastest growing region.

What Is Covered Under Cardiovascular Ultrasound Market?

Cardiovascular ultrasound is a noninvasive diagnostic method that utilizes high-frequency sound waves to generate images of the heart and its associated blood vessels. This imaging approach allows medical practitioners to observe the heart's chambers, valves, walls, and blood vessels, offering comprehensive insights into its structure and performance. The main types of cardiovascular ultrasounds are transthoracic echocardiography, transesophageal echocardiography, fetal echocardiography, and others. Transthoracic echocardiography (TTE) refers to a non-invasive diagnostic process that uses ultrasonic waves to produce images of the heart and its connected blood arteries. The various technologies are 2D, 3D or 4D, and Doppler with displays such as black or white (b/w) and color. The end uses are hospitals, diagnostic centers, ambulatory care centers, and others.

What Is The Cardiovascular Ultrasound Market Growth Forecast?

The cardiovascular ultrasound market size is expected to see strong growth in the next few years. It will grow to $3.79 billion in 2030 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to increasing demand for early disease detection, rising adoption of portable diagnostic devices, expansion of telecardiology services, growing investments in advanced imaging technologies, increasing focus on precision cardiology diagnostics. Major trends in the forecast period include increasing adoption of AI-assisted image interpretation, rising use of portable and point-of-care ultrasound systems, growing demand for high-resolution cardiac imaging, expansion of doppler-based diagnostic applications, enhanced focus on workflow integration and automation.

Global Cardiovascular Ultrasound Market Segmentation

1) By Type: Transthoracic Echocardiography, Transesophageal Echocardiography, Fetal Echocardiography 2) By Technology: 2D, 3D Or 4D, Doppler 3) By Display: Black Or White (B/W), Color 4) By End-Use: Hospital, Diagnostic Centers, Ambulatory Care Centers Subsegments: 1) By Transthoracic Echocardiography (TTE): Doppler Echocardiography, 2D Echocardiography, 3D Echocardiography, Stress Echocardiography 2) By Transesophageal Echocardiography (TEE): Adult TEE, Pediatric TEE 3) By Fetal Echocardiography: Standard Fetal Echocardiography, Advanced Fetal Echocardiography

What Is The Driver Of The Cardiovascular Ultrasound Market?

The increasing prevalence of cardiovascular disease is expected to propel the growth of the cardiovascular ultrasound market going forward. Cardiovascular disease (CVD) refers to a class of diseases that involve the heart or blood vessels. Cardiovascular ultrasound, also known as echocardiography, is a valuable and non-invasive imaging technique that plays a crucial role in the diagnosis, assessment, and management of cardiovascular diseases (CVD). For instance, in August 2025, according to the National Institutes of Health, a US-based government agency, between 2025 and 2050, cardiovascular prevalence is projected to rise by 90%, mortality by 73%, and DALYs by 55%, with deaths increasing from 20.5 million to 35.6 million. Therefore, the increasing prevalence of cardiovascular disease is driving the growth of the cardiovascular ultrasound industry.

Key Players In The Global Cardiovascular Ultrasound Market

Major companies operating in the cardiovascular ultrasound market are GE HealthCare Technologies Inc., Koninklijke Philips N.V., Siemens Healthineers AG, Hitachi Medical Corp., Samsung Medison Co. Ltd., Mindray Medical International Limited, Chison Wuxi Xiangsheng Medical Technology Co. Ltd., Fujifilm Sonosite Inc., Canon Medical Systems Corporation, Clarius Mobile Health, Dawei Medical (Jiangsu) Corp. Ltd., Esaote SpA, Fujifilm Holdings Corporation, Shenzhen Lanmage Medical Technology Co. Ltd., Leltek Inc., Telemed Ultrasound Medical Systems, Viatom Technology Co, Wuhan Zoncare Bio-medical Electronics Co. Ltd., Shenzhen Bestman Instrument Co. Ltd., Biim Ultrasound AS, Shenzhen WELLD Medical Electronics Co. Ltd.

Global Cardiovascular Ultrasound Market Trends and Insights

Major companies operating in the cardiovascular ultrasound market are focusing on developing new handheld ultrasound imaging systems, such as Vscan Air SL, to provide reliable services to customers. The Vscan Air SL handheld ultrasound imaging system is a portable device that uses ultrasound waves to create images of the body's internal structures when connected to a tablet or smartphone. For instance, in August 2023, GE HealthCare Technologies Inc., a US-based provider of medical technology, pharmaceutical diagnostics, and digital solutions, launched Vscan Air SL. This portable, wireless ultrasound imaging system can be used for rapid cardiac and vascular assessments to speed up diagnosis and treatment choices. The integration of SignalMax and XDclear, imaging performance technologies, is a unique feature of this system that allows for high penetration, resolution, and sensitivity levels using single crystal transducer technology. The new SL version contains a sector-phased array transducer for quick cardiac tests. Clinicians can bring Vscan Air to every patient due to the Vscan Air app, which is accessible on Android and iOS smartphones.

What Are Latest Mergers And Acquisitions In The Cardiovascular Ultrasound Market?

In March 2025, Boston Scientific Corporation, a US-based provider of interventional medical devices and cardiovascular therapy systems, acquired SoniVie Ltd. for an undisclosed amount. With this acquisition, Boston Scientific aims to bring SoniVie’s TIVUS™ intravascular ultrasound (IVUS) technology into its interventional portfolio to offer a minimally invasive, ultrasound-based therapy for hypertension via renal artery denervation. SoniVie Ltd. is a UK-based medical device company developing the TIVUS system a catheter-based intravascular ultrasound platform that delivers ultrasound energy to renal artery nerves to reduce blood pressure.

Regional Outlook

North America was the largest region in the cardiovascular ultrasound market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Cardiovascular Ultrasound Market?

The cardiovascular ultrasound market consists of revenues earned by entities by providing services such as diagnosis, consultation, telemedicine services, and vascular imaging services. The market value includes the value of related goods sold by the service provider or included within the service offering. The cardiovascular ultrasound market also includes sales of cardiac ultrasound machines, ultrasound probes, and Holter monitoring systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Cardiovascular Ultrasound Market Report 2026?

The cardiovascular ultrasound market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cardiovascular ultrasound industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.